CNBC Jim Cramer’s Five Investment Themes for 2026: Consumer spending, AI Infrastructure, Cybersecurity, M&A, MedTech and Healthcare innovation healthcare.digital
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
